Skip to main content
Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
6.13
+0.13 (2.17%)
May 2, 2024, 1:52 PM EDT - Market open

Verve Therapeutics Revenue

In the year 2023, Verve Therapeutics had annual revenue of $11.76M with 505.77% growth. Revenue in the quarter ending December 31, 2023 was $5.14M with 408.30% year-over-year growth.

Revenue (ttm)
$11.76M
Revenue Growth
+505.77%
P/S Ratio
41.62
Revenue / Employee
$46,110
Employees
255
Market Cap
480.72M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.76M9.82M505.77%
Dec 31, 20221.94M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetIQ 1.10B
UroGen Pharma 82.71M
Oculis Holding AG 1.05M
Altimmune 426.00K
Allogene Therapeutics 95.00K
Revenue Rankings

VERV News

More News